Many patients with macular disease have reduced visual acuity, which is thought to contribute to their problems with everyday visually guided behaviors such as reading and face discrimination (Rubin, Muñoz, Bandeen–Roche, & West,
2000). There is evidence that visual acuity can be improved by treatment, particularly in patients with wet age-related macular degeneration who are receiving anti-vascular endothelial growth factor injections (Avery et al.,
2006; Chang et al.,
2007; Fung et al.,
2007), and surgery for epiretinal membrane (Suh, Seo, Park, & Yu,
2009) and macular hole (Christensen et al.,
2010; Itoh, Inoue, Rii, Hiraoka, & Hirakata,
2012). Although improved acuity correlates with increased quality of life measures (Slakter & Stur,
2005), other symptoms including perceived spatial distortion (metamorphopsia) and reduced contrast sensitivity can persist after treatment (Liem, Keunen, van Meel, & van Norren,
1994; Richter-Mueksch et al.,
2007; Tolentino, Miller, Gaudio, & Sandberg,
1994; Wittich, Overbury, Kapusta, & Faubert,
2005).